Tarimah Khairunnisai, Bisri Dewi Yulianti, Halimi Radian Ahmad, Wiyarta Elvan
Department of Anesthesiology and Intensive Therapy Subdivision Neuroanesthesia and Critical Care, Dr Hasan Sadikin Hospital, Padjadjaran University, Bandung 40161, West Java, Indonesia.
Department of Anesthesiology and Intensive Therapy, RSUD Kota Mataram, Al-Azhar Islamic University Mataram, Mataram 83127, West Nusa Tenggara, Indonesia.
J Clin Med. 2025 Apr 1;14(7):2415. doi: 10.3390/jcm14072415.
Cerebral vasospasm after craniotomy tumor (CVACT) is a rare complication that can occur following tumor craniotomy and significantly affects the outcome of patients. Unfortunately, it is not well understood, leading to delayed and ineffective management. This study aims to investigate CVACT by examining the factors contributing to its occurrence, its underlying mechanisms, diagnostic approaches, management strategies, and outcomes. The goal is to identify the characteristics and risk factors associated with CVACT, its clinical symptoms, diagnostic methods, management options, and potential outcomes. A systematic search used relevant keywords to identify cases of "cerebral vasospasm" after tumor resection in PubMed and Science Direct databases. Relevant cross-references were added by manually searching the references of all retrieved articles. We included 60 inclusion patients from 14 case reports and 13 case series with 33 (55%) females and 27 (45%) males with a mean age of 44.05 ± 16.8 years. The most common tumors were pituitary adenomas, which were found in 22 (36.66%), the most common tumor location was the middle cranial fossa (75%), and the most common surgery technique used was transsphenoidal surgery (50%). Most of those who experience vasospasm have a craniotomy with the TSS technique (50%) with complications of intraoperative bleeding. The range of onset of VS symptoms postoperatively was 0-30 days (mean 6.59 d). The symptoms included asymptomatic, headache, loss of vision, hemiparesis, diplopia, etc. The vascular involvement was mainly anterior circulation (78.33%). The diagnostic tools most commonly used were angiography and transcranial doppler (TCD). The most common management of VS from the included studies was pharmacology. The survival rate was 61.66%. We found the tumor location and vascular-affected vasospasm were significantly correlated with mortality rates: = 0.015 and = 0.02. Cerebral vasospasm after craniotomy tumor removal (CVACT) frequently arises in tumors situated in the medial cranial fossa, predominantly pituitary adenomas and meningiomas. The minimally invasive surgical approach of TSS may contribute to the mechanism of CVACT incidence. The existence of preoperative vascular pathology, as encasement or narrowing, appears to be a predictor alongside the incidence of intra- or postoperative hemorrhage. The vascular structures most susceptible to vasospasm are located in the anterior circulation of the Willis circle, which appears to correlate with the vascular problems that typically undergo preoperative encasement of the internal carotid artery (ICA). The most reliable and real time diagnostic instrument employed is TCD, while imaging continues to be the gold standard. Nimodipine treatment continues to be a viable therapeutic option that can enhance patient outcomes.
开颅术后肿瘤相关性脑血管痉挛(CVACT)是一种罕见的并发症,可发生于肿瘤开颅术后,显著影响患者预后。遗憾的是,目前对此了解不足,导致治疗延迟且效果不佳。本研究旨在通过研究其发生的相关因素、潜在机制、诊断方法、治疗策略及预后,对CVACT进行调查。目标是确定与CVACT相关的特征和危险因素、其临床症状、诊断方法、治疗选择及潜在预后。通过系统检索,使用相关关键词在PubMed和ScienceDirect数据库中识别肿瘤切除术后“脑血管痉挛”的病例。通过手动检索所有检索文章的参考文献添加相关交叉引用。我们纳入了来自14篇病例报告和13个病例系列的60例符合纳入标准的患者,其中女性33例(55%),男性27例(45%),平均年龄44.05±16.8岁。最常见的肿瘤是垂体腺瘤,共22例(36.66%),最常见的肿瘤部位是中颅窝(75%),最常用的手术技术是经蝶窦手术(50%)。大多数发生血管痉挛的患者采用经蝶窦手术技术(TSS)开颅,伴有术中出血并发症。VS症状术后发作时间为0 - 30天(平均6.59天)。症状包括无症状、头痛、视力丧失、偏瘫、复视等。血管受累主要为前循环(78.33%)。最常用的诊断工具是血管造影和经颅多普勒(TCD)。纳入研究中VS最常见的治疗方法是药物治疗。生存率为61.66%。我们发现肿瘤部位和血管受累的血管痉挛与死亡率显著相关:P = 0.015和P = 0.02。开颅术后肿瘤切除术后的脑血管痉挛(CVACT)常发生于中颅窝的肿瘤,主要是垂体腺瘤和脑膜瘤。TSS的微创外科手术方法可能与CVACT的发生机制有关。术前血管病变的存在,如包绕或狭窄,似乎与术中和术后出血的发生率一样,是一个预测因素。最易发生血管痉挛的血管结构位于Willis环的前循环,这似乎与通常术前颈内动脉(ICA)被包绕的血管问题相关。所采用的最可靠和实时的诊断工具是TCD,而影像学仍然是金标准。尼莫地平治疗仍然是一种可行的治疗选择,可以改善患者预后。